Drug profile · INN
fluoxetine hydrochloride
FLUOXETINE HYDROCHLORIDE
fluoxetine hydrochloride (FLUOXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — fluoxetine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 14
- Data quality
- 0.89
Quick answer
fluoxetine hydrochloride (FLUOXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent serotonin transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is fluoxetine hydrochloride?
fluoxetine hydrochloride (FLUOXETINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fluoxetine hydrochloride?
FLUOXETINE HYDROCHLORIDE is a marketed brand name for fluoxetine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluoxetine hydrochloride?
fluoxetine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.